The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.
|Original language||English (US)|
|Number of pages||1|
|State||Published - Sep 1 2017|
ASJC Scopus subject areas
- Molecular Biology
- Biochemistry, Genetics and Molecular Biology(all)
- Immunology and Microbiology(all)